Menu Search
Equities

John Wiley & Sons Inc

2F7:FRA

John Wiley & Sons Inc

Actions
  • Price (EUR)47.40
  • Today's Change-0.600 / -1.25%
  • Shares traded500.00
  • 1 Year change+71.74%
  • Beta--
Data delayed at least 15 minutes, as of Nov 21 2024 07:19 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

John Wiley & Sons, Inc. is a publisher. The Company's content, services, platforms, and knowledge networks are tailored to meet the needs of its customers and partners, including researchers, students, instructors, professionals, institutions, and corporations. Its segments include Research, Learning and Held for Sale or Sold. Research segment provides peer-reviewed scientific, technical, and medical (STM) publishing, content platforms, and related services to academic, corporate, and government customers, academic societies, and individual researchers. Its journal publishing categories include the social sciences and humanities, and life sciences. Learning segment provides scientific, professional, and education print and digital books, digital courseware to libraries, corporations, students, professionals, and researchers, as well as assessment services to businesses and professionals. Its operations are located in the United States, United Kingdom, India, Sri Lanka, and Germany.

  • Revenue in USD (TTM)1.83bn
  • Net income in USD-109.49m
  • Incorporated1904
  • Employees6.40k
  • Location
    John Wiley & Sons Inc111 River StHOBOKEN 07030-5773United StatesUSA
  • Phone+1 (201) 748-6000
  • Fax+1 (201) 748-6088
  • Websitehttps://www.wiley.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.